Quick links

Secure login

Secure file transfer protocol

Register or renew user


Contact us

Trouble logging in? Forgot password? We can help!

philavax@phila.gov

215-685-6784

215-238-6944


Register a clinic

Fill out both forms, then either email or fax them to us at the contact above.

Clinic registration form
Enity confidentiality form

On behalf of patients

Patient update request

Looking for something else?

PhilaVax program info
Flat file reporting guide
More PhilaVax resources

Mpox

Become a Monkeypox Vaccine Provider Do you see patients who are at a higher risk of monkeypox infection? If so, please consider becoming a Jynneos vaccine provider and help stop the spread of monkeypox infection. The current patient eligibility guidelines are as follows: People who meet ALL of...

Monkeypox Vaccine Update: Expanded Eligibility & Second Doses There is now vaccine supply to begin administering a complete two-dose Jynneos vaccine series to each individual who is eligible for vaccine. Updates Eligibility for a first dose now includes:• People of all ages. Subcutaneous administration continues to be required...

Monkeypox Testing, Treatment, and Vaccine Resources Following PDPH's information session on Wednesday, August 17, we have included the slides from our presentation and follow up resources on monkeypox testing and treatment. Information for Healthcare Providers on Obtaining and Using TPOXX (Tecovirimat) for Treatment of Monkeypox CDC, in partnership with FDA,...

Monkeypox Update: Second Doses PDPH is recommending that providers who are currently offering monkeypox vaccine to their patients and individuals at highest risk to begin offering second doses of the JYNNEOS vaccine to patients who have received their first dose intradermally. The second dose is recommended 28...

Monkeypox Inventory Update and Ordering Cadence To facilitate the transition to intradermal (ID) administration of the Jynneos Monkeypox (MPX) vaccine, please: Accept all Monkeypox inventory into your inventory location. Use this guide. Complete an inventory reconciliation titled "SubQ to ID Transition," so that we have an accurate...

Monkeypox Update: Switch to JYNNEOS Intradermal Strategy Due to a shortage of doses, the PDPH recommends that providers switch to intradermal vaccination as soon as possible. Intradermal administration involves injecting the vaccine superficially between the epidermis and the hypodermis layers of the skin, typically of the inner...

Invitation to Discuss Monkeypox Testing, Treatment, and Vaccine FQHC Partners, On Wednesday, August 17, PDPH is inviting you to participate in a discussion about monkeypox testing, treatment, and vaccine. Please mark your calendars, and join using the meeting information below! PDPH is inviting you to a scheduled Zoom...

[vc_row][vc_column][vc_column_text] Updated Eligibility Criteria for Monkeypox Vaccine There has been a recent update in eligibility criteria for monkeypox vaccination, including sex workers of any sex or gender, as well as anyone who has had recent close contact with someone infected with monkeypox.Eligible individuals include: Gay, bisexual, transgender,...